Tenforde Mark W, Wake Rae, Leeme Tshepo, Jarvis Joseph N
Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA USA ; University of Washington Medical Center, 1959 NE Pacific Street, Health Sciences Division #356423, Seattle, WA 98195 USA.
Institute of Infection and Immunity, St. George's University of London, London, UK ; Centre for Opportunistic, Tropical and Hospital Infections, National Institute for Communicable Diseases, Johannesburg, South Africa ; National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, 2131 South Africa.
Curr Clin Microbiol Rep. 2016;3:92-102. doi: 10.1007/s40588-016-0035-5. Epub 2016 Mar 17.
Cryptococcal meningitis is a major cause of HIV-associated morbidity and mortality worldwide. Most cases occur in low-income countries, where over half of patients die within 10 weeks of diagnosis compared to as few as 10 % of patients from developed countries. A host of factors, spanning the HIV care continuum, are responsible for this gap in treatment outcomes between developed and resource-limited settings. We explore factors responsible for this outcomes gap and describe low-cost, highly effective measures that can be implemented immediately to improve outcomes in resource-limited settings. We also explore health-system challenges that must be addressed to reduce mortality further, recent research in disease prevention, and novel short-course treatment regimens that, if efficacious, could be implemented in resource-limited settings where the cost of standard treatment regimens is currently prohibitive.
隐球菌性脑膜炎是全球范围内与艾滋病相关的发病和死亡的主要原因。大多数病例发生在低收入国家,这些国家超过一半的患者在诊断后10周内死亡,而发达国家只有10%的患者死亡。从艾滋病护理的整个过程来看,许多因素导致了发达国家和资源有限地区在治疗结果上的这种差距。我们探讨造成这种结果差距的因素,并描述可以立即实施的低成本、高效措施,以改善资源有限地区的治疗结果。我们还探讨了为进一步降低死亡率必须解决的卫生系统挑战、疾病预防方面的最新研究,以及新型短疗程治疗方案,如果这些方案有效,可在资源有限地区实施,因为目前标准治疗方案的成本过高。